Risultati della ricerca - Intidhar Labidi-Galy

Editorial: PARP inhibitors resistance: new insights in ovarian cancer therapy di Oraianthi Fiste, Michalis Liontos, Sana Intidhar Labidi-Galy, Sana Intidhar Labidi-Galy

Testo

CldU sensitizes BRCA2 reverse-mutated cells to PARP inhibitors di Nawel Zouggari, Nawel Zouggari, Camilla Trugenberger, Camilla Trugenberger, Valentine Du Bois, Wenwen Wang, Giacomo G. Rossetti, Thanos D. Halazonetis, Intidhar Labidi-Galy, Intidhar Labidi-Galy

Testo

Ovarian stimulation with letrozole in nulliparous young women with relapsing early-stage serous borderline ovarian tumors di Valeria Lombardi Fäh, Federico Del Vento, S. Intidhar Labidi-Galy, Manuela Undurraga

Testo

Durable complete response with chemo-immuno-radiotherapy for metastatic cervical cancer progressing under immunotherapy: a case series di Thomas Westerhoff, Nathalie Baudoux, Manuela Undurraga, Patrick Petignat, Intidhar Labidi-Galy, Melpomeni Kountouri

Testo

Characteristics of long-survivor metastatic melanoma after polychemotherapy and interferon: a retrospective study di Céline Py, Claudio De Vito, Petros Tsantoulis, Gürkan Kaya, Sana Intidhar Labidi-Galy, Pierre-Yves Dietrich

Testo

Changes of health-related quality of life 6 months after high-risk oncological upper gastrointestinal and hepatobiliary surgery: a single-centre prospective observational study (Ch... di Delphine S Courvoisier, Christian Toso, Frederic Ris, Dina Zekry, Nadia Elia, Bernhard Walder, Julien Maillard, Stefan Mönig, Intidhar Labidi Galy, Isabelle Zaccaria

Testo

Chemotherapy-related agranulocytosis as a predictive factor for germline BRCA1 pathogenic variants in breast cancer patients: a retrospective cohort study di Noémie Lang, Aurélie Ayme, Chang Ming, Jean‑Damien Combes, Victor N. Chappuis, Alex Friedlaender, Aurélie Vuilleumier, José L. Sandoval, Valeria Viassolo, Pierre O. Chappuis, S. Intidhar Labidi-Galy

Testo